Skip to content

Rejuvel Bio-Sciences, Inc.

CIK 0001481427

← back to feed
Revenue (TTM)
$147.96K
−25.2% YoY Q3 Nov 2015
Net Income (TTM)
$931.1K
+30.6% YoY Q3 Nov 2015
EPS Diluted (TTM)
$0.00
Q3 Nov 2015
Gross Margin
85.6%
Q3 Nov 2015
Operating Margin
-761.8%
Q3 Nov 2015
Net Margin
629.3%
Q3 Nov 2015
Free Cash Flow (TTM)
—
Q3 Nov 2015
Cash
$877
Q3 Nov 2015
Total Debt
—
Q3 Nov 2015
Shares Outstanding
51.84M sh
Q3 Nov 2015

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings